NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
27/07/2025
Voltar para busca
Dado oficial do USPTO
TAIJI
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
44
Atualização mais recente
19/08/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5
Data de depósito
11/04/2001
Data de registro
03/08/2004
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
27/07/2025
Última transação
19/08/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
800
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
18/03/1986
Primeiro uso no comércio
20/05/2000
Código do desenho
3
Tipo de titular
03
Localização do titular
CHONGQING, CN
Examinador
LEIPZIG, MARC
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
TAIJI GROUP,CHONGQING FULING PHARMACEUTICAL FACTORY
TAI JI GROUP FU LING PHARMACEUTICAL FACTORY
Representantes
Nazly Aileen Bayramoglu Bayramoglu Law Offices LLC
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Medicinal preparations for human use for use in the treatment of hypertension, headaches, [ dermatological diseases, ] cardiovascular diseases, [ lymphatic diseases, psychiatric diseases, skeletal diseases, muscular diseases, cancer, ] gastrointestinal diseases, [ allergies, insomnia, depression, anxiety, stress, urological diseases, diabetes, ] heart diseases, [ hepatitis, infectious diseases, arthritis, acne, neurological disease, of the nervous system, eye conditions, tendonitis, treatment of libido problems; pharmaceutical preparations of microorganisms for medical use in treating humans and for veterinary use in treating livestock, domesticated pets, and domesticated animals, for use in the treatment of hypertension, headaches, dermatological diseases, cardiovascular diseases, lymphatic diseases, psychiatric diseases, skeletal diseases, muscular diseases, cancer, gastrointestinal diseases, allergies, insomnia, depression, anxiety, stress, urological diseases, diabetes, heart diseases, hepatitis, infectious diseases, arthritis, acne, neurological diseases of the nervous system, eye conditions, tendonitis, treatment of libido problems; pharmaceutical preparations of organisms for use in the treatment of hypertension, headaches, dermatological diseases, cardiovascular diseases, lymphatic diseases, psychiatric diseases, skeletal diseases, muscular diseases, cancer, gastrointestinal diseases, allergies insomnia depression, anxiety, stress, urological diseases, diabetes, heart diseases, hepatitis, infectious diseases, arthritis, acne, neurological diseases of the nervous system, eye conditions, tendonitis, treatment of libido problems; ] drugs for medical use, namely, medications used to treat hypertension, headaches, [ dermatological diseases, ] cardiovascular diseases, [ lymphatic diseases, psychiatric diseases, skeletal diseases, muscular diseases, cancer, ] gastrointestinal diseases, [ allergies, insomnia, depression, anxiety, stress, urological diseases, diabetes, ] heart diseases [ , hepatitis, infectious diseases, arthritis, acne, neurological diseases of the nervous system, eye conditions, tendonitis, treatment of libido problems; foods for medically restricted diets ]
Publicações
Histórico de despachos e eventos da marca no USPTO.
44 publicações encontradas
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
27/07/2025
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
27/07/2025
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
25/02/2025
PUM1
OFFICE ACTION ISSUED POU1
26/08/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
26/08/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
01/08/2024
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
03/08/2023
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
30/09/2013
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
30/09/2013
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
30/09/2013
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
30/09/2013
89AF
REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
27/09/2013
E89R
TEAS SECTION 8 & 9 RECEIVED
27/09/2013
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
27/09/2013
WOAG
WITHDRAWAL OF ATTORNEY GRANTED
06/10/2009
WOAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
06/10/2009
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
30/09/2009
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
30/09/2009
ES8R
TEAS SECTION 8 RECEIVED
01/09/2009
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
15/07/2009
R.PR
REGISTERED-PRINCIPAL REGISTER
03/08/2004
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
25/05/2004
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/05/2004
FAXX
FAX RECEIVED
04/05/2004
CNRT
NON-FINAL ACTION MAILED
22/03/2004
DOCK
ASSIGNED TO EXAMINER
19/03/2004
CFIT
CASE FILE IN TICRS
18/03/2004
SUPC
STATEMENT OF USE PROCESSING COMPLETE
10/03/2004
PAPER RECEIVED
09/02/2004
IUAF
USE AMENDMENT FILED
05/02/2004
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
05/08/2003
PUBO
PUBLISHED FOR OPPOSITION
13/05/2003
NPUB
NOTICE OF PUBLICATION
23/04/2003
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/02/2003
CNEA
EXAMINERS AMENDMENT MAILED
03/02/2003
CNFR
FINAL REFUSAL MAILED
01/11/2002
DOCK
ASSIGNED TO EXAMINER
30/09/2002
REIN
REINSTATED
27/09/2002
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/06/2002
PETR
PETITION TO REVIVE-RECEIVED
13/06/2002
ABN2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
07/06/2002
CNRT
NON-FINAL ACTION MAILED
15/08/2001
DOCK
ASSIGNED TO EXAMINER
20/07/2001
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace TAIJI ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.